DiscoverGreen Mountain MedicineEpisode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective
Episode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective

Episode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective

Update: 2020-10-24
Share

Description

In this episode, we are joined by Internal Medicine PGY-3s and soon-to-be fellows Dr. Carrie Mahurin and Dr. Jen Bergeron. Together, they review the evidence for or against a broadened therapeutic role of SGLT2 Inhibitors beyond diabetes treatment, in light of new trials suggesting efficacy in heart failure and chronic kidney disease management.


 


Guests: Dr. Carrie Mahurin, MD, PGY3 at UVMMC, and Dr. Jen Bergeron, MD, PGY3 at UVMMC


 


Thumbnail by Kate Hliznitsova on Unsplash

Comments 
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective

Episode 12: SGLT2 Inhibitors - A Cardiac vs Renal Perspective

ACPVermont